Bruce Booth, Director, on June 17, 2026, sold 31,798 shares in Kymera Therapeutics (KYMR) for $3,299,037. Following the Form 4 filing with the SEC, Booth has control over a total of 4,076,518 common shares of the company, with 4,076,518 controlled indirectly.
SEC Filing: